Mode
Text Size
Log in / Sign up

Psychological and behavioral interventions significantly reduce depression severity in people with epilepsyBehavioral Therapies May Help Reduce Depression in People with Epilepsy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider cognitive behavioral therapy or self-management programs to reduce depression in patients with epilepsy.

This meta-analysis evaluates the impact of various psychological and behavioral interventions, including cognitive behavioral therapy (CBT), mindfulness-based interventions, self-management or collaborative-care programs, and relaxation-based interventions, on depression severity in individuals with epilepsy. The analysis compared these interventions against treatment as usual or control conditions.

The meta-analysis found a significant reduction in depression severity with an overall effect size of SMD = -0.63 (95% CI: -0.90 to -0.36). Specific modalities also showed significant benefits: cognitive behavioral therapy (SMD = -0.55, 95% CI: -0.90 to -0.21), mindfulness-based interventions (SMD = -0.46, 95% CI: -0.86 to -0.07), and self-management or collaborative-care (SMD = -0.43, 95% CI: -0.74 to -0.12). A large effect was noted for progressive muscle relaxation (SMD = -1.65), though this was based on a single small study.

Several limitations were noted, including a lack of blinding, reliance on self-reported outcomes, and incomplete outcome reporting. The authors highlight that the certainty of evidence is low to very low across all intervention categories. While these interventions may help reduce depressive symptoms, the evidence for progressive muscle relaxation is considered preliminary. Clinical application should be weighed against the low certainty of evidence and the specific limitations of the included studies.

How this fits prior evidence

This meta-analysis addresses a gap in managing the psychological comorbidities of epilepsy. While prior evidence indicates that managing sleep disturbances and obstructive sleep apnea may improve quality of life in epilepsy, this finding adds evidence that psychological and behavioral interventions can specifically target and reduce depression severity in this population. The findings for cognitive behavioral therapy and self-management programs provide the most consistent evidence for clinical consideration.

This review looked at how different psychological and behavioral treatments affect depression in people with epilepsy. The researchers compared several methods, including cognitive behavioral therapy, mindfulness, self-management programs, and relaxation techniques, against standard care.

The results showed that these behavioral interventions significantly reduced depression severity compared to standard care. Specifically, cognitive behavioral therapy and self-management or collaborative-care programs showed consistent benefits. While mindfulness and muscle relaxation also showed positive results, the evidence for those specific methods was less certain or based on very small studies.

It is important to note that the overall certainty of the evidence is low to very low. The study also faced challenges like a lack of blinding and a reliance on self-reported data. While these therapies show potential for managing depression in epilepsy patients, the results are not yet definitive enough to change standard medical practice immediately.

What this means for you:
Behavioral therapies like cognitive behavioral therapy may help reduce depression in people with epilepsy.

Common questions

What types of therapy were found to help with depression in epilepsy?

Several types of behavioral interventions showed a significant reduction in depression severity. These included cognitive behavioral therapy, mindfulness-based interventions, self-management or collaborative-care programs, and relaxation-based interventions. Cognitive behavioral therapy and self-management programs provided the most consistent evidence for helping patients.

Is the evidence for these treatments very strong?

The evidence for these interventions is currently considered to be of low to very low certainty. This is because of factors like the lack of blinding in studies and the use of self-reported outcomes. Because the evidence is not yet certain, these findings should be discussed with a doctor.

Are there any specific treatments that had limited data?

The evidence for progressive muscle relaxation was based on a single small study, making it preliminary. While it showed a large effect in that specific instance, the overall evidence for this particular method is limited compared to other interventions like cognitive behavioral therapy.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BackgroundDepression is a common and clinically important comorbidity in people with epilepsy and is associated with poorer quality of life, impaired treatment adherence, increased disease burden, and worse clinical outcomes. Psychological and behavioral interventions have been increasingly applied in this population; however, the overall efficacy and consistency of evidence across different intervention categories remain uncertain.ObjectiveThis systematic review and meta-analysis aimed to evaluate the effects of psychological and behavioral interventions on depressive symptoms in people with epilepsy, with particular attention to cognitive behavioral therapy, mindfulness-based interventions, self-management or collaborative-care programs, and relaxation-based interventions.MethodsA systematic literature search was conducted in PubMed, Embase, Web of Science, MEDLINE, and Cochrane Library for studies published between January 2005 and May 2026. Randomized controlled trials and controlled clinical studies evaluating eligible interventions for depression-related outcomes in people with epilepsy were included. The primary outcome was depression severity measured using validated rating scales. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated for continuous outcomes. Random-effects models were used to account for clinical and methodological heterogeneity. Risk of bias and certainty of evidence were assessed using the Cochrane RoB 2 tool and the GRADE framework, respectively.ResultsTwenty-two studies were included in the systematic review, of which 11 contributed data to the quantitative synthesis of continuous depression severity outcomes. Overall, active psychological and behavioral interventions were associated with significantly greater reductions in depressive symptoms compared with treatment as usual or control conditions (SMD = −0.63, 95% CI: −0.90 to −0.36). In subgroup analyses, cognitive behavioral therapy showed a significant beneficial effect (SMD = −0.55, 95% CI: −0.90 to −0.21), as did mindfulness-based interventions (SMD = −0.46, 95% CI: −0.86 to −0.07) and self-management or collaborative-care interventions (SMD = −0.43, 95% CI: −0.74 to −0.12). Progressive muscle relaxation showed a large effect in a single small study (SMD = −1.65), but this finding should be interpreted cautiously because of limited evidence. Most studies were judged as having some concerns regarding risk of bias, mainly due to lack of blinding, reliance on self-reported outcomes, and incomplete outcome reporting. The certainty of evidence ranged from low to very low across intervention categories.ConclusionPsychological and behavioral interventions may help reduce depressive symptoms in people with epilepsy. Among the available intervention categories, cognitive behavioral therapy and self-management or collaborative-care interventions showed the most consistent and clinically interpretable evidence. Mindfulness-based interventions may also be beneficial, although the overall certainty of evidence remained low. Findings for progressive muscle relaxation remain preliminary. Further well-designed, adequately powered randomized trials with standardized outcome measures and longer follow-up are needed to confirm these findings.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261403546, PROSPERO CRD420261403546.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.